Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenge


5. Non-Invasive Aesthetic Treatment Market


6. Market Share

6.1 By Procedure
6.2 By Gender
6.3 By End User
6.4 By Countries


7. Procedure

7.1 Injectables

7.1.1 Botulinum Toxin
7.1.2 Hyaluronic Acid
7.1.3 Calcium Hydroxylapatite
7.1.4 Poly-L-Lactic Acid

7.2 Facial Rejuvenation

7.2.1 Photo Rejuvenation
7.2.2 Chemical peel
7.2.3 Micro Ablative Resurfacing
7.2.4 Full field Ablative

7.3 Others

7.3.1 Hair Removal
7.3.2 Non Surgical Fat Reduction


8. Gender

8.1 Male
8.2 Female


9. End User

9.1 Hospital/surgery centre
9.2 Medspa
9.3 Traditional Spa
9.4 HCP Owned Clinic


10. Countries

10.1 United States
10.2 Brazil
10.3 Japan
10.4 Mexico
10.5 Turkey
10.6 Germany
10.7 Argentina
10.8 Italy
10.9 Colombia
10.10 India
10.11 Spain
10.12 Greece
10.13 Iran
10.14 Romania
10.15 United Kingdom
10.16 Thailand
10.17 Rest of the world


11. Porter’s Five Forces Analysis

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Business Overview
13.1.2 Key Persons
13.1.3 Product Portfolio
13.1.4 Recent Development
13.1.5 Sales Analysis

13.2 Bausch Health Companies Inc.

13.2.1 Business Overview
13.2.2 Key Persons
13.2.3 Product Portfolio
13.2.4 Recent Development
13.2.5 Sales Analysis

13.3 Cutera Inc.

13.3.1 Business Overview
13.3.2 Key Persons
13.3.3 Product Portfolio
13.3.4 Recent Development
13.3.5 Sales Analysis

13.4 AbbVie Inc.

13.4.1 Business Overview
13.4.2 Key Persons
13.4.3 Product Portfolio
13.4.4 Recent Development
13.4.5 Sales Analysis

13.5 Sisram Medical Ltd.

13.5.1 Business Overview
13.5.2 Key Persons
13.5.3 Product Portfolio
13.5.4 Recent Development
13.5.5 Sales Analysis

13.6 Galderma S.A

13.6.1 Business Overview
13.6.2 Key Persons
13.6.3 Product Portfolio
13.6.4 Recent Development
13.6.5 Sales Analysis

13.7 Sientra Inc.

13.7.1 Business Overview
13.7.2 Key Persons
13.7.3 Product Portfolio
13.7.4 Recent Development
13.7.5 Sales Analysis

13.8 Revance Therapeutics Inc.

13.8.1 Business Overview
13.8.2 Key Persons
13.8.3 Product Portfolio
13.8.4 Recent Development
13.8.5 Sales Analysis